CSIMarket
 
Ladrx Corporation  (CYTR)
Other Ticker:  
 
   Industry ../Industry/industry_valuation_ttm.php?pc&ind=801"> Biotechnology & Pharmaceuticals
   Sector  Healthcare
 
Price: $0.0920 $0.00 0.000%
Day's High: $0.1 Week Perf: 2.22 %
Day's Low: $ 0.09 30 Day Perf: 18.71 %
Volume (M): 4 52 Wk High: $ 0.45
Volume (M$): $ 0 52 Wk Avg: $0.14
Open: $0.09 52 Wk Low: $0.05



 Market Capitalization (Millions $) 4
 Shares Outstanding (Millions) 45
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0

Ladrx Corporation


   Company Address: 11726 San Vicente Blvd. Los Angeles 90049 CA
   Company Phone Number: 826-5648   Stock Exchange / Ticker: CYTR
   CYTR is expected to report next financial results on March 22, 2023.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Kludein I Acquisition Corp

Existing costs were building up at the company in the fourth quarter of 2022

Trailing the large companies in the Cloud Computing & Data Analytics industry, some lesser known corporations are publishing the respective numbers. Kludein I Acquisition Corp told it has announced operating shortfall of $-1.141717 millions, for the fourth quarter of 2022.

Zedge Inc

Deterioration in Earnings while Sales rose at the ZDGE over the November to January 31 2023 period

Sales growth of 0.983 %, could not prevent income decline of -31.25 % in the most recent fiscal period, compared to comparable financial reporting period a year before. Sales were at $6.98 millions and eps at $0.11.

Ftac Zeus Acquisition Corp

Ftac Zeus Acquisition Corp published Sales of $3.452357 millions, in the fiscal period ending December 31 2022

the Blank Checks company proclaimed $3.452357 millions, in Sales in the fiscal period ending December 31 2022.

Eiger Biopharmaceuticals Inc

Evanescence of Deficit at the Biotechnology & Pharmaceuticals company in the financial time-frame ending December 31 2022

For the financial time-frame ending December 31 2022 Eiger Biopharmaceuticals Inc managed to cut its losses on diminishing revenue, where shortfall per share were at $-0.46 relative to $-0.64 and revenue decreased by -19.762 % to $2.70 millions relative to $3.36 millions in the same quarter a year before.

Sprott Esg Gold Etf

For the October to December 31 2022 span Sprott Esg Gold Etf had turn a round to income by exhibiting EPS of $1.89 per share compare to $-0.64 a year before and income per share turned positive from $-2.11 per share from the preceding quarter.

Sales remained unaffected to $0.00 millions from $3.36 millions in the corresponding quarter a year before and sequentially Sales Tumbled from $0.00 millions.






 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ADCT's Profile

Stock Price

ADCT's Financials

Business Description

Fundamentals

Charts & Quotes

ADCT's News

Suppliers

ADCT's Competitors

Customers & Markets

Economic Indicators

ADCT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071